RecruitingNCT05618080
LGMD R1 Natural History Study
Studying Calpain-3-related limb-girdle muscular dystrophy R1
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Virginia Commonwealth University
- Principal Investigator
- Nicholas Johnson, MDVirginia Commonwealth University
- Enrollment
- 100 enrolled
- Eligibility
- 12-50 years · All sexes
- Timeline
- 2024 – 2028
Study locations (12)
- University of California, Irvine, Orange, California, United States
- University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
- University of Florida, Gainesville, Florida, United States
- The Community Health Clinic, Inc., Shipshewana, Indiana, United States
- University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- University of Minnesota, Department of Neurology, Minneapolis, Minnesota, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
- Virginia Commonwealth University, Richmond, Virginia, United States
- Leiden University Medical Center, Leiden, Netherlands
- Newcastle University, Newcastle upon Tyne, United Kingdom
Collaborators
Nationwide Children's Hospital · Washington University School of Medicine · University of Iowa · University of Florida · University of Minnesota · Newcastle University · University of Kansas Medical Center · University of Colorado, Denver · Indiana CHC (Community Health Clinic) · University of California, Irvine
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05618080 on ClinicalTrials.govOther trials for Calpain-3-related limb-girdle muscular dystrophy R1
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT05230459A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)AskBio Inc
- ENROLLING BY INVITATIONNCT04989751A Multicenter Phenotype-Genotype Analysis of LGMD Patients in ChinaHuashan Hospital
See all trials for Calpain-3-related limb-girdle muscular dystrophy R1 →